BrianLeePearlmanMD

Internal Medicine • Atlanta, GA

Hospital Medicine/Hospitalist

Physician

Join to view full profile

Dr. Pearlman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Pearlman's full profile

Already have an account?

Office
285 Boulevard Ne
Suite 140
Atlanta, GA 30312
Phone+1 404-265-1044

Fax+1 404-265-1047
Is this information wrong?

Education & Training

Baylor University Medical CenterResidency, Internal Medicine, 1993 - 1996
University of Texas Southwestern Medical Center/Parkland Memorial HospitalInternship, Transitional Year, 1992 - 1993
University of Miami Leonard M. Miller School of MedicineClass of 1992

Certifications & Licensure

GA State Medical License 1996 - 2025
TX State Medical License 1993 - 2000
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Clinical Trials

The SIM-SOF Trial for Hepatitis C Start of enrollment: 2013 Dec 01
Completed
Phase 4
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects Start of enrollment: 2017 Apr 20
Completed
Phase 3

Publications & Presentations

PubMed

Erratum to: Hepatitis Delta Infection: A Clinical Review.
Brian Pearlman> ;Seminars in Liver Disease. 2023 Aug 1
1 citations
Hepatitis Delta Infection: A Clinical Review.
Brian Pearlman> ;Seminars in Liver Disease. 2023 Aug 1
1 citations
Renin secreting tumour: a rare cause of secondary hypertension.
Brian L. Pearlman, Bereket T Lodebo> ;Lancet. 2021 Sep 18
3 citations
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Mark S. Sulkowski, Juhi S Moon, Kenneth E. Sherman, Giuseppe Morelli, Jama M. Darling, Andrew J. Muir, Mandana Khalili, Dawn Fishbein, Federico Hinestrosa, Mitchell L....> ;Hepatology. 2021 Aug 26
Management of Hepatitis C–Infected Patients After Sustained Virological Response
Brian L. Pearlman> ;Clinical Liver Disease. 2020 Jul 1
1 citations
How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease
Brian L. Pearlman> ;Annals of Internal Medicine. 2019 Dec 3
28 citations
Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection.
Brian L. Pearlman, Michael Perrys, Andrew Hinds> ;The American Journal of Gastroenterology. 2019 Sep 1
28 citations
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.
Anna S. Lok, Mark S. Sulkowski, Jens Kort, Ira Willner, K. Rajender Reddy, Mitchell L. Shiffman, Mohamed Hassan, Brian L. Pearlman, Federico Hinestrosa, Ira M. Jacobso...> ;Gastroenterology. 2019 Dec 1
9 citations
Review article: novel antivirals for hepatitis C-sofosbuvir/velpatasvir/voxilaprevir, glecaprevir/pibrentasvir.
Brian L. Pearlman, Andrew Hinds> ;Alimentary Pharmacology & Therapeutics. 2018 Nov 1
1 citations
Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192.
Brian L. Pearlman, Andrew Hinds, Alexandra-Elise Zakaud Dakaud> ;Diabetes Care. 2018 Sep 1
2 citations
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
Philippe J Zamor, John M Vierling, Reem Ghalib, Velimir Luketic, Natarajan Ravendhran, Luis A. Balart, Michael Robertson, Peggy Hwang, George J Hanna, Bach-Yen Nguyen,...> ;The American Journal of Gastroenterology. 2018 Apr 26
34 citations
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.
Zobair M. Younossi, Maria Stepanova, Ira M. Jacobson, Tarik Asselah, E.J. Gane, E.J. Lawitz, Graham R. Foster, Stuart K. Roberts, Alexander J. Thompson, Bernard Willem...> ;Alimentary Pharmacology & Therapeutics. 2018 Jan 1
9 citations
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis...
Eric Lawitz, Maria Buti, John M. Vierling, Piero Luigi Almasio, Savino Bruno, Peter Ruane, Tarek Hassanein, Beat Muellhaupt, Brian L. Pearlman, Ligita Jancoriene, Wei ...> ;The Lancet. Gastroenterology & Hepatology. 2017 Nov 1
170 citations
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Ira M. Jacobson, Eric Lawitz, Edward Gane, Bernard Willems, Peter Ruane, Ronald Nahass, Sergio Borgia, Stephen D. Shafran, Kimberly A. Workowski, Brian L. Pearlman, Ro...> ;Gastroenterology. 2017 Jul 1
6 citations
Increased Mitochondrial Genetic Diversity in Persons Infected With Hepatitis C Virus
David S. Campo, Ha-Jung Roh, Brian L. Pearlman, Daniel S. Fierer, Sumathi Ramachandran, Gilberto Vaughan, Andrew Hinds, Zoya Dimitrova, Pavel Skums, Yury Khudyakov> ;Cellular and Molecular Gastroenterology and Hepatology. 2016 Sep 1
127 citations
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection
Paul Y. Kwo, Edward Gane, Cheng Yuan Peng, Brian L. Pearlman, John M. Vierling, Lawrence Serfaty, Maria Buti, Stephen D. Shafran, Paul Stryszak, Li Lin, Jacqueline Gre...> ;Gastroenterology. 2017 Jan 1
9 citations
Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
Anjana Pillai, Frank A. Anania, Brian L. Pearlman> ;The American Journal of Gastroenterology. 2016 Dec 1
42 citations
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial
Eric Lawitz, Nancy Reau, Federico Hinestrosa, Mordechai Rabinovitz, Eugene R. Schiff, Aasim Sheikh, Ziad Younes, Robert Herring, K. Rajender Reddy, Tram Tran, Michael ...> ;Gastroenterology. 2016 Nov 1
1 citations
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.
Maribel Rodriguez-Torres, Eric Lawitz, Bienvenido G. Yangco, Lennox J. Jeffers, Steven Han, Paul J. Thuluvath, Vinod K. Rustgi, Stephen A. Harrison, Reem Ghalib, John ...> ;Annals of Hepatology. 2016 Nov 1
146 citations
Effectiveness of Simeprevir Plus Sofosbuvir, with or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection
Mark S. Sulkowski, Hugo E. Vargas, Adrian M. Di Bisceglie, Alexander Kuo, K. Rajender Reddy, Joseph K. Lim, Giuseppe Morelli, Jama M. Darling, Jordan J. Feld, Robert S...> ;Gastroenterology. 2016 Feb 1
50 citations
The Combination of Simeprevir and Sofosbuvir Is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients With Hepatitis C–Related Child's Clas...
Brian L. Pearlman, Carole Ehleben, Michael Perrys> ;Gastroenterology. 2015 Apr 1
226 citations
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype...
Eric Lawitz, Edward Gane, Brian L. Pearlman, Edward Tam, Wayne Ghesquiere, Dominique Guyader, Laurent Alric, Jean-Pierre Bronowicki, Laura Lester, William Sievert, Ree...> ;Lancet. 2015 Mar 21
80 citations
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.
Stuart C. Gordon, Andrew J. Muir, Joseph K. Lim, Brian L. Pearlman, Curtis K. Argo, Ananthakrishnan Ramani, Benedict Maliakkal, Imtiaz Alam, Thomas G. Stewart, Monika ...> ;Journal of Hepatology. 2015 Feb 1
613 citations
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribav...
Eric Lawitz, Mark S. Sulkowski, Reem Ghalib, Maribel Rodriguez-Torres, Zobair M. Younossi, Ana Corregidor, Edwin DeJesus, Brian L. Pearlman, Mordechai Rabinovitz, Norm...> ;Lancet. 2014 Nov 15
4 citations
The New Cholesterol Treatment Guidelines from the American College of Cardiology/American Heart Association, 2013: What Clinicians Need to Know
Tanna H. Lim, Israel B. Orija, Brian L. Pearlman> ;Postgraduate Medicine. 2014 Nov 1
Join now to see all

Journal Articles

Comment on Bril Et Al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192
Brian Pearlman, MD, Diabetes Care

Press Mentions

Jaundice, Malaise in Woman with Heroin Habit, Inactive Hepatitis BJuly 5th, 2022
Helping Clinicians Keep Pace with Advances in Hepatitis C Virus TreatmentMay 24th, 2021
CDC Warns Baby Boomers to Get Tested for Hepatitis CMay 3rd, 2017
Join now to see all

Hospital Affiliations

Wellstar Atlanta Medical CenterAtlanta, Georgia

BrianLeePearlmanMD

Dr. Pearlman is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.